NEW DELHI (Reuters) – India’s drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech. The world’s second most populous country is now expected to start a massive immunisation programme within weeks, with the AstraZeneca/Oxford shot taking the lead and Bharat Biotech’s COVAXIN administered under stricter conditions given no efficacy data has been release for it. The overall efficacy of the AstraZeneca/Oxford vaccine was 70.42 percent, while Bharat Biotech’s COVAXIN was “safe and provides a robust immune response”, Drugs Controller General of India V.G
Hence then, the article about india approves astrazeneca and local covid vaccines rollout in weeks was published today ( ) and is available onEGYPT INDEPENDENT ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( India approves AstraZeneca and local COVID vaccines, rollout in weeks )